News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
653,639 Results
Type
Article (55675)
Company Profile (296)
Press Release (597655)
Multimedia
Podcasts (161)
Webinars (25)
Section
Business (170831)
Career Advice (2476)
Deals (31269)
Drug Delivery (154)
Drug Development (80042)
Employer Resources (161)
FDA (16916)
Job Trends (13557)
News (306785)
Policy (32503)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2732)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (166)
Alliances (44357)
ALS (206)
Alzheimer's disease (1885)
Antibody-drug conjugate (ADC) (394)
Approvals (17140)
Artificial intelligence (635)
Autoimmune disease (249)
Automation (48)
Bankruptcy (329)
Best Places to Work (10541)
BIOSECURE Act (23)
Biosimilars (215)
Biotechnology (194)
Bladder cancer (182)
Brain cancer (71)
Breast cancer (689)
Cancer (5450)
Cardiovascular disease (496)
Career advice (2100)
Career pathing (44)
CAR-T (305)
CDC (71)
Celiac Disease (2)
Cell therapy (849)
Cervical cancer (43)
Clinical research (68853)
Collaboration (1947)
Company closure (6)
Compensation (1287)
Complete response letters (91)
COVID-19 (2915)
CRISPR (103)
C-suite (994)
Cystic fibrosis (157)
Data (7085)
Decentralized trials (3)
Denatured (41)
Depression (171)
Dermatology (59)
Diabetes (567)
Diagnostics (6671)
Digital health (46)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (312)
Drug pricing (233)
Drug shortages (33)
Duchenne muscular dystrophy (285)
Earnings (70791)
Editorial (71)
Employer branding (20)
Employer resources (144)
Events (100772)
Executive appointments (1034)
FDA (20400)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1625)
Gene editing (228)
Generative AI (58)
Gene therapy (732)
GLP-1 (1176)
Government (4752)
Grass and pollen (8)
Guidances (395)
Healthcare (17297)
HIV (78)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (326)
Immuno-oncology (85)
Indications (157)
Infectious disease (3256)
Inflammatory bowel disease (223)
Inflation Reduction Act (14)
Influenza (133)
Intellectual property (279)
Interviews (457)
IPO (15478)
IRA (58)
Job creations (3385)
Job search strategy (1716)
JPM (70)
Kidney cancer (19)
Labor market (91)
Layoffs (639)
Leadership (44)
Legal (7427)
Liver cancer (105)
Longevity (27)
Lung cancer (741)
Lymphoma (410)
Machine learning (52)
Management (53)
Manufacturing (920)
MASH (193)
Medical device (12722)
Medtech (12794)
Mergers & acquisitions (16936)
Metabolic disorders (1547)
mRNA (208)
Multiple sclerosis (182)
NASH (24)
Neurodegenerative disease (434)
Neuropsychiatric disorders (114)
Neuroscience (3392)
Neurotech (2)
NextGen: Class of 2026 (5820)
Non-profit (4495)
Now hiring (50)
Obesity (762)
Opinion (310)
Ovarian cancer (183)
Pain (228)
Pancreatic cancer (261)
Parkinson's disease (364)
Partnered (29)
Patents (563)
Patient recruitment (603)
Peanut (62)
People (52445)
Pharmaceutical (68)
Pharmacy benefit managers (34)
Phase 1 (21105)
Phase 2 (30165)
Phase 3 (23183)
Pipeline (7107)
Policy (361)
Postmarket research (2634)
Preclinical (8893)
Press Release (49)
Prostate cancer (284)
Psychedelics (60)
Radiopharmaceuticals (295)
Rare diseases (1110)
Real estate (4956)
Recruiting (66)
Regulatory (25515)
Reports (46)
Research institute (2531)
Resumes & cover letters (411)
Rett syndrome (33)
RNA editing (21)
RSV (94)
Schizophrenia (176)
Series A (280)
Series B (203)
Service/supplier (9)
Sickle cell disease (115)
Special edition (27)
Spinal muscular atrophy (182)
Sponsored (51)
Startups (3353)
State (1)
Stomach cancer (21)
Supply chain (120)
Tariffs (102)
The Weekly (118)
Vaccines (1203)
Venture capital (109)
Weight loss (521)
Women's health (101)
Worklife (23)
Date
Today (39)
Last 7 days (632)
Last 30 days (2691)
Last 365 days (30487)
2026 (8108)
2025 (30751)
2024 (34816)
2023 (39047)
2022 (49934)
2021 (53849)
2020 (51460)
2019 (41906)
2018 (31779)
2017 (31572)
2016 (30472)
2015 (34220)
2014 (27052)
2013 (22277)
2012 (23661)
2011 (23921)
2010 (22154)
Location
Africa (834)
Alabama (80)
Alaska (6)
Arizona (277)
Arkansas (12)
Asia (38910)
Australia (6758)
California (12141)
Canada (3199)
China (1261)
Colorado (495)
Connecticut (542)
Delaware (356)
Europe (92608)
Florida (1819)
Georgia (377)
Hawaii (4)
Idaho (59)
Illinois (921)
India (72)
Indiana (526)
Iowa (23)
Japan (490)
Kansas (122)
Kentucky (41)
Louisiana (38)
Maine (77)
Maryland (1494)
Massachusetts (8848)
Michigan (309)
Minnesota (655)
Mississippi (6)
Missouri (139)
Montana (29)
Nebraska (27)
Nevada (131)
New Hampshire (73)
New Jersey (3284)
New Mexico (23)
New York (3215)
North Carolina (1572)
North Dakota (8)
Northern California (6048)
Ohio (350)
Oklahoma (21)
Oregon (41)
Pennsylvania (2377)
Puerto Rico (20)
Rhode Island (40)
South America (1179)
South Carolina (75)
South Dakota (1)
Southern California (4737)
Tennessee (182)
Texas (1896)
United States (42932)
Utah (348)
Virginia (302)
Washington D.C. (79)
Washington State (975)
West Virginia (4)
Wisconsin (128)
Wyoming (1)
653,639 Results for "parkinson s disease foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
FDA Warns of Seizure Risk With Some Parkinson’s Drugs
The FDA detected 14 cases of vitamin B6 deficiency–linked seizures and two deaths in patients with Parkinson’s disease taking carbidopa/levodopa drugs. Both AbbVie and Novartis market levodopa-based products.
March 23, 2026
·
2 min read
·
Tristan Manalac
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve motor function and mobility in patients.
March 23, 2026
·
2 min read
·
Tristan Manalac
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Parkinson’s disease
5 Investigational Therapies That Could Change the Parkinson’s Landscape
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC Immune, Gain Therapeutics and more could shape the future of Parkinson’s disease treatment.
January 26, 2026
·
9 min read
·
Tristan Manalac
Press Releases
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
March 18, 2026
·
8 min read
Press Releases
Groundbreaking Danish research project launches to cure Parkinson’s disease
March 23, 2026
·
4 min read
Press Releases
Casma Therapeutics Receives MJFF Support to Advance Research on TRPML1 in Parkinson’s Disease
March 10, 2026
·
5 min read
Press Releases
Bexorg Awarded Grant from The Michael J. Fox Foundation to Identify Translational Biomarkers for TRPML1-Targeted Parkinson’s Disease Therapies
January 29, 2026
·
4 min read
Press Releases
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
March 16, 2026
·
5 min read
Press Releases
Immunis Licenses Treatment Candidate for Dyskinesia Associated with Parkinson’s Disease
March 5, 2026
·
4 min read
1 of 65,364
Next
